Navigation Links
Canadian Healthy Vending Hits Manufacturing Milestone
Date:3/27/2013

ucts and make requests from their local operators, and the remote monitoring capability built into each Max! machine allows operators to monitor sales selections, make inventory decisions from their web browser and quickly update stock at individual locations.

During off-hours, Canadian Healthy Vending Centres have energy-saving technology to minimize the energy used by lights and vending functions.

Max! machines look after the consumer with the Health Guard Function, based on safe food handling policies in Canadian jurisdictions. For example, with perishable items, temperature monitoring ensures that only fresh, safe products are sold.

“The phenomenal success we’ve experienced is a strong indicator that Canadians are ready for healthier snacks at work, school and play. The popularity of the Max! Canadian Healthy Vending Centres is also due to the high quality experience the up-to-date interface provides today’s information-savvy consumers. It seems like only a few weeks ago we were discussing the concept and completing our prototypes. Now we’re ready to install our next 1000!” – Shaun Casey, VP Marketing, Canadian Healthy Vending

About Canadian Healthy Vending
Canadian Healthy Vending is a Vancouver-based vending equipment manufacturer and distributor with over 23 years experience in the Canadian vending industry and is the manufacturer of the Max! Healthy Vending Machine. Our Mission is to get healthy snacks and nutritious drinks into the hands of Canadian workers and students in every city and province across the country. The state-of-the-art Max! Healthy Vending Machine features both cash and cashless payment systems in addition to a high resolution display monitor, which provides nutritional information on product offerings, and information on community health initiatives. To get more information about Canadian Healthy Vending or to get a Max! Healthy Vending Machine at your workplace visit the

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Canadians Feeling the Stress of Tax Season Should Remember to Take Their B Vitamins
2. Leading Canadian health researchers honored
3. Canadian adult obesity at historic high
4. STEMSOFT and The Canadian Blood and Marrow Transplant Group Announce Partnership
5. ISA Surgical Publishes Real Stories of the Benefits of Medical Tourism In Mexico From US And Canadian Patients
6. Babies born to mothers from the Philippines significantly smaller than those of Canadian-born women
7. Top Canadian, Indian institutions form $30M partnership
8. Canadian scientists discover cause of high cholesterol
9. Canadian otolaryngologist wins international award
10. Canadian researcher is on a mission to create an equal playing field at the Paralympic Games
11. Medical complications in hospitalized children: The Canadian Paediatric Adverse Events Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... 2014 Recently, BellasDress has ... its wedding dresses. BellasDress has chosen their best-selling lace ... choices for the holiday season. , Now, BellasDress.com ... wedding gowns here at discount prices. The business hopes ... its website. , “All our elegant products ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
(Date:12/25/2014)... 2014 (HealthDay News) -- The risk of burns from ... you need to be extra cautious, an expert says. ... a significant increase in patients coming in with burns," ... County Volunteer Firefighters Burn Center of Stony Brook University ... full of joy, but if not careful, could quickly ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... could be closing in on a "fountain of youth" drug ... health of older adults, a new study suggests. Seniors ... a drug that targets a genetic signaling pathway linked to ... report. The experimental medication, a version of ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... Calif., March 20 Poniard Pharmaceuticals, Inc. (Nasdaq: ... on oncology, today announced that it will concentrate ... development of its late-stage oncology candidate, picoplatin. As ... preclinical research operations and reduced its workforce by ...
... Qutenza(TM) Receives Positive Committee Recommendation in European ... approval of Qutenza(TM) (formerly NGX-4010) for treatment ... either alone or in combination with other ... for review by U.S. FDA for PHNUpcoming ...
... March 20 Nuvilex, Inc. (OTC Bulletin Board: NVLX), formerly ... for the live conference call held on March 19, 2009 ... March 19, 2009 at 7:30 PM ET to March 26, ... 1-877-660-6853 (U.S.) and 1-201-612-7415 (international). To listen to the ...
... A campaign which will reduce mortality in patients with ... coalition which includes the ESC Working Group on Acute ... Interventions (EAPCI). "Stent 4 Life" is a project designed ... percutaneous coronary interventions (PCI, with balloon angioplasty and stent) ...
... leading private equity investment fund ("JLL"), and PharmaNet Development ... (Nasdaq: PDGI ) ("PharmaNet"), today announced the ... Holdings, LLC ("Parent"), through its wholly-owned subsidiary, PDGI Acquisition ... common stock of PharmaNet. Parent and Purchaser are ...
... to work, maybe you can walk at work ... 3 is National Walk to Work Day. ... Human Services, the sixth-annual event encourages Americans to ... http://www.newscom.com/cgi-bin/prnh/20090320/DE86407 )The reason is clear: According to ...
Cached Medicine News:Health News:Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization 2Health News:Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization 3Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 2Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 3Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 4Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 5Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 6Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 7Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 8Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 9Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 10Health News:NeurogesX Reports Fourth Quarter and Year-End 2008 Results 11Health News:Nuvilex Provides Conference Call Replay Information 2Health News:'Stent 4 Life': A campaign is launched to increase the use of primary PCI in acute coronary patients 2Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 2Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 3Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 4Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 5Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 6Health News:JLL Partners Announces Acceptance for Payment of Shares Tendered in PharmaNet Tender Offer and Commencement of Subsequent Offering Period 7Health News:National Walk to Work Day is April 3 2Health News:National Walk to Work Day is April 3 3
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, ... PTN), a biopharmaceutical company developing targeted, receptor-specific peptide ... unmet medical need and commercial potential, today announced ... of 2,050,000 shares of its common stock and ... its common stock.  Funds under the management of ...
(Date:12/24/2014)...  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a ... development of brachytherapy devices and medical isotopes for ... has filed a de novo submission ... marketing clearance for its patented Y-90 RadioGel(TM) device ... Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... MITI ), a biopharmaceutical company developing novel, ... autoimmune,diseases, announced the start of a phase 1 ... will explore the safety, pharmacokinetics,pharmacodynamics and anti-tumor activity ... MT110 targets the epithelial cell adhesion molecule ...
... an oncolytic product, WOBURN, Mass., April 22 ... treatments for cancer and the prevention,of infectious disease, ... (FDA) has approved the design of a single, ... OncoVEX(GM-CSF) in,previously treated patients with metastatic melanoma. The ...
Cached Medicine Technology:Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 2Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 3Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 4Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors 5BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 2BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO 3
CVC 223 is an assayed quality control material used for confirming the calibration and linearity of CO-Oximeter instrumentation....
... control material used for monitoring the performance of ... for specific use on Bayer analyzers that measure ... 270) and the AVOX Systems CO-Oximeters (4000 and ... the IRMA TRUpoint. CC 527 is available in ...
RNA1c Control is an assayed quality control material used for monitoring the performance of Bayer DCA Analyzers that measure Hemoglobin A1c. It may be used on DCA 2000 and 2000+ analyzers....
... is a reagent and probe system used ... high throughput plate based system is a ... a unique approach for RNA detection and ... branched DNA (bDNA) technology. Branched DNA allows ...
Medicine Products: